HLA-G/C, miRNAs, and their role in HIV infection and replication

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Celsi, Fulvio ^a   Catamo, Eulalia ^b   Kleiner, Giulio ^a   Tricarico, Paola Maura ^b   Vuch, Josef ^b   Crovella, Sergio ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HLA C ANTIGEN; HLA G ANTIGEN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 29A; MICRORNA 29B; PIWI INTERACTING RNA; RIBOSOME RNA; SINGLE STRANDED RNA; SMALL NUCLEOLAR RNA; SMALL UNTRANSLATED RNA; TRANSFER RNA; VIRUS RNA;

ANTIGEN EXPRESSION; DISEASE COURSE; GENE EXPRESSION REGULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HLA-C ANTIGENS; HLA-G ANTIGENS; HUMANS; IMMUNE SYSTEM; MICRORNAS;

EID: 84880173579     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/693643     Document Type: Review

References (91)

1. Apps R., Qi Y., Carlson J. M., Influence of HLA-C expression level on HIV control. Science 2013 340 6128 87 91
2. + T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01-AE infected thais. PLoS ONE 2011 6 8 2-s2.0-80051942027 10.1371/journal.pone.0023603 e23603
3. Fellay J., Shianna K. V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J. M., Obel N., Smith J. P., Wyniger J., Descombes P., Antonarakis S. E., Letvin N. L., McMichael A. J., Haynes B. F., Telenti A., Goldstein D. B., A whole-genome association study of major determinants for host control of HIV-1. Science 2007 317 5840 944 947 2-s2.0-34548134145 10.1126/science.1143767
4. Trachtenberg E., Bhattacharya T., Ladner M., Phair J., Erlich H., Wolinsky S., The HLA-B/-C haplotype block contains major determinants for host control of HIV. Genes and Immunity 2009 10 8 673 677 2-s2.0-73849122765 10.1038/gene.2009.58
5. Segat L., Catamo E., Fabris A., Morgutti M., D'Agaro P., Campello C., Crovella S., HLA-G0105N allele is associated with augmented risk for HIV infection in white female patients. AIDS 2010 24 12 1961 1964 2-s2.0-77954761518 10.1097/QAD.0b013e32833c3324
6. Larsen M. H., Zinyama R., Kallestrup P., HLA-G 3′ untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected zimbabwean population. The Journal of Infectious Diseases 2013 207 6 903 906
7. Cullen B. R., HIV-1 auxiliary proteins: making connections in a dying cell. Cell 1998 93 5 685 692 2-s2.0-0032577444 10.1016/S0092-8674(00)81431-2
8. Frankel A. D., Young J. A. T., HIV-1: fifteen proteins and an RNA. Annual Review of Biochemistry 1998 67 1 25 2-s2.0-0031711593 10.1146/annurev.biochem. 67.1.1
9. Littman D. R., Chemokine receptors: keys to AIDS pathogenesis? Cell 1998 93 5 677 680 2-s2.0-0032577581 10.1016/S0092-8674(00)81429-4
10. Karn J., Stoltzfus C. M., Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harbor Perspectives in Medicine 2012 2 2
11. Wright M. W., Bruford E. A., Naming "junk": human non-protein coding RNA (ncRNA) gene nomenclature. Human Genomics 2011 5 2 90 98 2-s2.0-79955788276
12. Amaral P. P., Clark M. B., Gascoigne D. K., Dinger M. E., Mattick J. S., LncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Research 2011 39 1 D146 D151 2-s2.0-78651325932 10.1093/nar/gkq1138
13. Thomson T., Lin H., The biogenesis and function of PIWI proteins and piRNAs: progress and prospect. Annual Review of Cell and Developmental Biology 2009 25 355 376 2-s2.0-70350238350 10.1146/annurev.cellbio.24.110707.175327
14. Mattick J. S., Makunin I. V., Small regulatory RNAs in mammals. Human Molecular Genetics 2005 14 1 R121 R132 2-s2.0-15944402920 10.1093/hmg/ddi101
15. Adams E. J., Parham P., Species-specific evolution of MHC class I genes in the higher primates. Immunological Reviews 2001 183 41 64 2-s2.0-0035667937 10.1034/j.1600-065X.2001.1830104.x
16. Groothuis T. A. M., Griekspoor A. C., Neijssen J. J., Herberts C. A., Neefjes J. J., MHC class I alleles and their exploration of the antigen-processing machinery. Immunological Reviews 2005 207 60 76 2-s2.0-26244461898 10.1111/j.0105-2896.2005.00305.x
17. Paul P., Adrian Cabestre F., Ibrahim E. C., Lefebvre S., Khalil-Daher I., Vazeux G., Moya Quiles R. M., Bermond F., Dausset J., Carosella E. D., Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Human Immunology 2000 61 11 1138 1149 2-s2.0-0034516969 10.1016/S0198-8859(00)00197-X
18. Antoniou A. N., Powis S. J., Elliott T., Assembly and export of MHC class I peptide ligands. Current Opinion in Immunology 2003 15 1 75 81 2-s2.0-0037290828 10.1016/S0952-7915(02)00010-9
19. Hill A. V. S., Genetic susceptibility to malaria and other infectious diseases: from the MHC to the whole genome. Parasitology 1996 112 supplement S75 S84 2-s2.0-0029888419
20. Neisig A., Melief C. J. M., Neefjes J., Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. Journal of Immunology 1998 160 1 171 179 2-s2.0-0031930271
21. Falk C. S., Schendel D. J., HLA-C revisited. Ten years of change. Immunologic Research 1997 16 2 203 214 2-s2.0-0030739176
22. Colonna M., Borsellino G., Falco M., Ferrara G. B., Strominger J. L., HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proceedings of the National Academy of Sciences of the United States of America 1993 90 24 12000 12004 2-s2.0-0027132097 10.1073/pnas.90.24.12000
23. Khakoo S. I., Thio C. L., Martin M. P., Brooks C. R., Gao X., Astemborski J., Cheng J., Goedert J. J., Vlahov D., Hilgartner M., Cox S., Little A.-M., Alexander G. J., Cramp M. E., O'Brien S. J., Rosenberg W. M. C., Thomas D. L., Carrington M., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004 305 5685 872 874 2-s2.0-3843075120 10.1126/science.1097670
24. Tiemessen C. T., Paximadis M., Minevich G., Winchester R., Shalekoff S., Gray G. E., Sherman G. G., Coovadia A. H., Kuhn L., Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. Journal of Acquired Immune Deficiency Syndromes 2011 57 3 181 189 2-s2.0-79959706621 10.1097/QAI.0b013e3182174a76
25. Collins K. L., Chen B. K., Kalams S. A., Walker B. D., Baltimore D., HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998 391 6665 397 401 2-s2.0-0032556872 10.1038/34929
26. Alcami A., Koszinowski U. H., Viral mechanisms of immune evasion. Trends in Microbiology 2000 8 9 410 418 2-s2.0-0034283057 10.1016/S0966-842X(00)01830-8
27. Thomas R., Apps R., Qi Y., Gao X., Male V., O'Huigin C., O'Connor G., Ge D., Fellay J., Martin J. N., Margolick J., Goedert J. J., Buchbinder S., Kirk G. D., Martin M. P., Telenti A., Deeks S. G., Walker B. D., Goldstein D., McVicar D. W., Moffett A., Carrington M., HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nature Genetics 2009 41 12 1290 1294 2-s2.0-70649112117 10.1038/ng.486
28. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., Carosella E. D., Paul P., IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. International Immunology 1999 11 5 803 811 2-s2.0-0032913576 10.1093/intimm/11.5.803
29. Cirulli V., Zalatan J., McMaster M., Prinsen R., Salomon D. R., Ricordi C., Torbett B. E., Meda P., Crisa L., The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006 55 5 1214 1222 2-s2.0-33745295348 10.2337/db05-0731
30. Yan W.-H., HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy. Endocrine, Metabolic and Immune Disorders 2011 11 1 76 89 2-s2.0-79953021083
31. Carosella E. D., Paul P., Moreau P., Rouas-Freiss N., HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunology Today 2000 21 11 532 534 2-s2.0-0033666756 10.1016/S0167-5699(00)01707-2
32. Rouas-Freiss N., Marchal R. E., Kirszenbaum M., Dausset J., Carosella E. D., The α 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proceedings of the National Academy of Sciences of the United States of America 1997 94 10 5249 5254 2-s2.0-0030612605 10.1073/pnas.94.10.5249
33. Lozano J. M., González R., Kindelán J. M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E. D., Peña J., Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002 16 3 347 351 2-s2.0-0037083937 10.1097/00002030-200202150-00005
34. Onno M., Pangault C., Le Friec G., Guilloux V., André P., Fauchetz R., Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. Journal of Immunology 2000 164 12 6426 6434 2-s2.0-0034659769
35. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G., Trono D., HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nature Cell Biology 2000 2 3 163 167 2-s2.0-0033776709 10.1038/35004038
36. Williams M., Roeth J. F., Kasper M. R., Fleis R. I., Przybycin C. G., Collins K. L., Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. Journal of Virology 2002 76 23 12173 12184 2-s2.0-0036889125 10.1128/JVI.76.23.12173-12184.2002
37. Schwartz O., Maréchal V., Le Gall S., Lemonnier F., Heard J.-M., Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 1996 2 3 338 342 2-s2.0-0029875421 10.1038/nm0396-338
38. Gall S. L., Buseyne F., Trocha A., Walker B. D., Heard J.-M., Schwartz O., Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. Journal of Virology 2000 74 19 9256 9266 2-s2.0-0033798906 10.1128/JVI.74.19.9256-9266.2000
39. Greenberg M. E., Lafrate A. J., Skowronski J., The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. The EMBO Journal 1998 17 10 2777 2789 2-s2.0-0032525137 10.1093/emboj/17.10.2777
40. Kasper M. R., Collins K. L., Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. Journal of Virology 2003 77 5 3041 3049 2-s2.0-0037370728 10.1128/JVI.77.5.3041-3049.2003
41. Cohen G. B., Gandhi R. T., Davis D. M., Mandelboim O., Chen B. K., Strominger J. L., Baltimore D., The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999 10 6 661 671 2-s2.0-0033151621 10.1016/S1074-7613(00) 80065-5
42. Pizzato N., Derrien M., Lenfant F., The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Human Immunology 2004 65 11 1389 1396 2-s2.0-8844284445 10.1016/j.humimm.2004. 07.239
43. Nattermann J., Nischalke H. D., Hofmeister V., Kupfer B., Ahlenstiel G., Feldmann G., Rockstroh J., Weiss E. H., Sauerbruch T., Spengler U., HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antiviral Therapy 2005 10 1 95 107 2-s2.0-18044365482
44. Barcova M., Kacani L., Speth C., Dierich M. P., gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon- γ production. Journal of Infectious Diseases 1998 177 4 905 913 2-s2.0-0031978597
45. Matte C., Lajoie J., Lacaille J., Zijenah L. S., Ward B. J., Roger M., Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 2004 18 3 427 431 2-s2.0-1642300418 10.1097/00002030-200402200-00008
46. Derrien M., Pizzato N., Dolcini G., Menu E., Chaouat G., Lenfant F., Barré-Sinoussi F., Le Bouteiller P., Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. The Journal of General Virology 2004 85 7 1945 1954 2-s2.0-3343019387 10.1099/vir.0.79867-0
47. Lenfant F., Pizzato N., Liang S., Davrinche C., Le Bouteiller P., Horuzsko A., Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. The Journal of General Virology 2003 84 2 307 317 2-s2.0-0037311252 10.1099/vir.0.18735-0
48. Lozano J. M., González R., Kindelán J. M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E. D., Peña J., Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002 16 3 347 351 2-s2.0-0037083937 10.1097/00002030-200202150-00005
49. Donaghy L., Gros F., Amiot L., Mary C., Maillard A., Guiguen C., Gangneux J.-P., Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clinical and Experimental Immunology 2007 147 2 236 240 2-s2.0-33846251260 10.1111/j.1365-2249.2006.03268.x
50. Murdaca G., Contini P., Setti M., Cagnati P., Lantieri F., Indiveri F., Puppo F., Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution. Clinical Immunology 2009 133 2 238 244 2-s2.0-70349785082 10.1016/j.clim.2009.08.002
51. Rebmann V., Busemann A., Lindemann M., Grosse-Wilde H., Detection of HLA-G5 secreting cells. Human Immunology 2003 64 11 1017 1024 2-s2.0-0242609925 10.1016/j.humimm.2003.08.354
52. Lajoie J., Fontaine J., Tremblay C., Routy J.-P., Poudrier J., Roger M., Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 2009 23 11 1437 1440 2-s2.0-68449093189 10.1097/QAD.0b013e32832d0825
53. Hazenberg M. D., Otto S. A., Van Benthem B. H. B., Roos M. T. L., Coutinho R. A., Lange J. M. A., Hamann D., Prins M., Miedema F., Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003 17 13 1881 1888 2-s2.0-0041327667 10.1097/00002030-200309050-00006
54. Turk W. J. R., Kimani J., Bielawny T., Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort. AIDS 2013 27 1 7 15
55. Le Discorde M., Le Danff C., Moreau P., Rouas-Freiss N., Carosella E. D., HLA-G0105N null allele encodes functional HLA-G isoforms. Biology of Reproduction 2005 73 2 280 288 2-s2.0-22544457479 10.1095/biolreprod.104.037986
56. Castro M. J., Morales P., Martinez-Laso J., Allende L., Rojo-Amigo R., Gonzalez-Hevilla M., Varela P., Moscoso J., Garcia-Berciano M., Arnaiz-Villena A., Lack of MHC-G4 and soluble (G5, G6) isoforms in the higher primates, Pongidae. Human Immunology 2000 61 11 1164 1168 2-s2.0-0034523096 10.1016/S0198-8859(00)00189-0
57. Castelli E. C., Moreau P., Chiromatzo A. O. E., Mendes-Junior C. T., Veiga-Castelli L. C., Yaghi L., Giuliatti S., Carosella E. D., Donadi E. A., In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes. Human Immunology 2009 70 12 1020 1025 2-s2.0-70350702674 10.1016/j.humimm.2009.07.028
58. Zhu X.-M., Han T., Wang X.-H., Li Y.-H., Yang H.-G., Luo Y.-N., Yin G.-W., Yao Y.-Q., Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. American Journal of Obstetrics and Gynecology 2010 202 6 592.e1 592.e7 2-s2.0-77952876059 10.1016/j.ajog.2010.03.002
59. Manaster I., Goldman-Wohl D., Greenfield C., Nachmani D., Tsukerman P., Hamani Y., Yagel S., Mandelboim O., MiRNA-mediated control of HLA-G expression and function. PLoS ONE 2012 7 3 2-s2.0-84858416153 10.1371/journal.pone.0033395 e33395
60. Snary D., Barnstable C. J., Bodmer W. F., Crumpton M. J., Molecular structure of human histocompatibility antigens: the HLA-C series. European Journal of Immunology 1977 7 8 580 585 2-s2.0-0017748275
61. Kulkarni S., Savan R., Qi Y., Gao X., Yuki Y., Bass S. E., Martin M. P., Hunt P., Deeks S. G., Telenti A., Pereyra F., Goldstein D., Wolinsky S., Walker B., Young H. A., Carrington M., Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011 472 7344 495 498 2-s2.0-79955542187 10.1038/nature09914
62. Neefjes J. J., Ploegh H. L., Allele and locus-specific differences in cell surface expression and the association of HLA class I heavb chain with β 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. European Journal of Immunology 1988 18 5 801 810 2-s2.0-0023883452
63. Specht A., Telenti A., Martinez R., Fellay J., Bailes E., Evans D. T., Carrington M., Hahn B. H., Goldstein D. B., Kirchhoff F., Counteraction of HLA-C-mediated immune control of HIV-1 by Nef. Journal of Virology 2010 84 14 7300 7311 2-s2.0-77953798625 10.1128/JVI.00619-10
64. Fellay J., Ge D., Shianna K. V., Colombo S., Ledergerber B., Cirulli E. T., Urban T. J., Zhang K., Gumbs C. E., Smith J. P., Castagna A., Cozzi-Lepri A., De Luca A., Easterbrook P., Günthard H. F., Mallal S., Mussini C., Dalmau J., Martinez-Picado J., Miro J. M., Obel N., Wolinsky S. M., Martinson J. J., Detels R., Margolick J. B., Jacobson L. P., Descombes P., Antonarakis S. E., Beckmann J. S., O'Brien S. J., Letvin N. L., McMichael A. J., Haynes B. F., Carrington M., Feng S., Telenti A., Goldstein D. B., Common genetic variation and the control of HIV-1 in humans. PLoS Genetics 2009 5 12 2-s2.0-74249086566 10.1371/journal.pgen.1000791 1000791
65. Corrah T. W., Goonetilleke N., Kopycinski J., Deeks S. G., Cohen M. S., Borrow P., McMichael A., Brackenridge S., Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. Journal of Virology 2011 85 7 3367 3374 2-s2.0-79952603435 10.1128/JVI.02276-10
66. Gatignol A., Laine S., Clerzius G., Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology 2005 2, article 65 2-s2.0-27744458277 10.1186/1742-4690-2-65
67. Qian S., Zhong X., Yu L., Ding B., De Haan P., Boris-Lawrie K., HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proceedings of the National Academy of Sciences of the United States of America 2009 106 2 605 610 2-s2.0-58849125280 10.1073/pnas.0806822106
68. Bivalkar-Mehla S., Vakharia J., Mehla R., Abreha M., Kanwar J. R., Tikoo A., Chauhan A., Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system. Virus Research 2011 155 1 1 9 2-s2.0-78650575533 10.1016/j.virusres.2010.10.003
69. Hayes A. M., Qian S., Yu L., Boris-Lawrie K., Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. Retrovirology 2011 8 1, article 36 2-s2.0-79955794490 10.1186/1742-4690-8-36
70. Sun G., Li H., Wu X., Covarrubias M., Scherer L., Meinking K., Luk B., Chomchan P., Alluin J., Gombart A. F., Rossi J. J., Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Research 2012 40 5 2181 2196 2-s2.0-84858396784 10.1093/nar/gkr961
71. Krakauer D. C., Nowak M., T cell induced pathogenesis in HIV: bystander effects and latent infection. Proceedings of the Royal Society B 1999 266 1423 1069 1075 2-s2.0-0033594671 10.1098/rspb.1999.0745
72. Houzet L., Yeung M. L., de Lame V., Desai D., Smith S. M., Jeang K.-T., MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 2008 5 1, article 118 2-s2.0-61349100846 10.1186/1742-4690-5-118
73. + T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 2012 9 1, article 5 2-s2.0-84855570512 10.1186/1742-4690-9-5
74. + T lymphocytes. Nature Medicine 2007 13 10 1241 1247 2-s2.0-34948817683 10.1038/nm1639
75. Ahluwalia J. K., Khan S. Z., Soni K., Rawat P., Gupta A., Hariharan M., Scaria V., Lalwani M., Pillai B., Mitra D., Brahmachari S. K., Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008 5, article 117 2-s2.0-61449173947 10.1186/1742-4690-5-117
76. + T cells and monocytes. Viruses 2012 4 9 1390 1409
77. Chiang K., Liu H., Rice A. P., miR-132 enhances HIV-1 replication. Virology 2013 438 1 1 4 10.1016/j.virol.2012.12.016
78. Chang S. T., Thomas M. J., Sova P., Green R. R., Palermo R. E., Katze M. G., Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microRNA expression patterns and candidate novel microRNAs differentially expressed upon infection. MBio 2013 4 1 10.1128/mBio.00549-12
79. Sung T.-L., Rice A. P., miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathogens 2009 5 1 2-s2.0-59249084325 10.1371/journal.ppat.1000263 e1000263
80. Sisk J. M., Clements J. E., Witwer K. W., miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction. Viruses 2012 4 12 1844 1864
81. Wang X., Ye L., Hou W., Zhou Y., Wang Y.-J., Metzger D. S., Ho W.-Z., Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009 113 3 671 674 2-s2.0-60249083292 10.1182/blood-2008-09-175000
82. Swaminathan S., Zaunders J., Wilkinson J., Suzuki K., Kelleher A. D., Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection? Blood 2009 113 20 5029 5030 2-s2.0-66549115937 10.1182/blood-2009-01-196741
83. Bennasser Y., Le S.-Y., Yeung M. L., Jeang K.-T., HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 2004 1, article 43 2-s2.0-14344260087 10.1186/1742-4690-1-43
84. Bennasser Y., Le S.-Y., Benkirane M., Jeang K.-T., Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005 22 5 607 619 2-s2.0-19344370167 10.1016/j.immuni.2005.03.010
85. Omoto S., Ito M., Tsutsumi Y., Ichikawa Y., Okuyama H., Brisibe E. A., Saksena N. K., Fujii Y. R., HIV-1 nef suppression by virally encoded microRNA. Retrovirology 2004 1, article 44 2-s2.0-14744284227 10.1186/1742-4690-1-44
86. Omoto S., Fujii Y. R., Regulation of human immunodeficiency virus 1 transcription by nef microRNA. Journal of General Virology 2005 86 3 751 755 2-s2.0-14744297918 10.1099/vir.0.80449-0
87. Klase Z., Winograd R., Davis J., Carpio L., Hildreth R., Heydarian M., Fu S., McCaffrey T., Meiri E., Ayash-Rashkovsky M., Gilad S., Bentwich Z., Kashanchi F., HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 2009 6, article 18 2-s2.0-62749139614 10.1186/1742-4690-6-18
88. Lin J., Cullen B. R., Analysis of the interaction of primate retroviruses with the human RNA interference machinery. Journal of Virology 2007 81 22 12218 12226 2-s2.0-36048994739 10.1128/JVI.01390-07
89. Yeung M. L., Bennasser Y., Watashi K., Le S.-Y., Houzet L., Jeang K.-T., Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Research 2009 37 19 6575 6586 2-s2.0-70449604918 10.1093/nar/gkp707
90. Whisnant A. W., Bogerd H. P., Flores O., In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio 2013 4 2
91. Alkhouly N., Shehata I., Ahmed M. B., Shehata H., Hassan S., Ibrahim T., HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker. Medical Oncology 2013 30 1